Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-02-24 @ 2:31 PM
Study NCT ID:
NCT02419612
Status:
COMPLETED
Last Update Posted:
2020-06-23
First Post:
2015-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-14
First Submit QC Date:
None
Study First Post Date:
2015-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-12
Results First Submit QC Date:
None
Results First Post Date:
2018-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-22
Last Update Post Date:
2020-06-23
Last Update Post Date Type:
ACTUAL